Skip to content
OpenCapital
Get started

Bio-Rad Laboratories, Inc. BIO.B Q1 2026 earnings

Reported April 30, 2026 · Before market open

Revenue$592.1MBeat by $784.1KDiluted EPS$1.89Miss by $0.12
Revenue estimate$591.3M
EPS estimate$2.01

Next report

Jul 30, 2026 (in a month)
Revenue estimate$624.8M
EPS estimate$1.78

Financials

Q1 2026

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation & ratios

Q1 2026

Valuation

See full
Market cap$7.52B+10.3%
Enterprise value$8B+4.2%
P/E44.6×—
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Segments

By geography

See full
Europe$206.8M+3.5%
Asia Pacific$110.4M+6.1%
Americas$45.1M+13.3%

By segment

See full
Clinical Diagnostics$363.6M+1.9%
Life Science$228.5M0.0%

Versus estimates

Revenue

Q1 2026$592.1MBeat by $784.1K
Q4 2025$693.2MBeat by $5.2MQ3 2025$653.0MBeat by $1.5MQ2 2025$651.6MMiss by $55.0MQ1 2025$585.4MBeat by $12.2MQ4 2024$667.5MMiss by $12.3M

Diluted EPS

Q1 2026$1.89Miss by $0.12
Q4 2025$2.51Miss by $0.18Q3 2025-$12.70Miss by $14.59Q2 2025$11.67Beat by $9.92Q1 2025$2.29Beat by $0.47Q4 2024-$25.57Miss by $28.43

Ask the moment Bio-Rad Laboratories, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Bio-Rad Laboratories, Inc. report Q1 2026 earnings?
Bio-Rad Laboratories, Inc. (BIO.B) reported Q1 2026 earnings on April 30, 2026 before market open.
What were Bio-Rad Laboratories, Inc.'s Q1 2026 revenue and EPS?
Bio-Rad Laboratories, Inc. reported revenue of $592.1M and diluted EPS of $1.89 for Q1 2026.
Did Bio-Rad Laboratories, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $591.3M by $784.1K. EPS missed the consensus estimate of $2.01 by $0.12.
How did Bio-Rad Laboratories, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1.1% from $585.4M a year earlier and diluted EPS declined 17.5% from $2.29.
Where can I find Bio-Rad Laboratories, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0000012208-26-000034) and the 10-Q periodic report (0000012208-26-000035) directly on SEC EDGAR. The filing index links above go to sec.gov.